RSCM
SLRN

Rock Springs Capital Management’s ACELYRIN SLRN Stock Holding History

Rock Springs Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-141,876
Closed -$1.44M – 112
2023
Q3 		$1.44M Hold
141,876
– – 0.04% 104
2023
Q2 		$2.97M Buy
+141,876
New +$2.9M 0.07% 97

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rock Springs Capital Management's SLRN Position: Q4 2023 in Review

Rock Springs Capital Management sold out of ACELYRIN (SLRN) in Q4 2023, closing a stake of 141,876 shares — an estimated $1.44M sold.

Rock Springs Capital Management first reported a position in SLRN in Q2 2023 and held it in 2 quarters. The position peaked at $2.97M in Q2 2023. 110 funds tracked by Wall St. Rank hold SLRN as of Q4 2023.

  • Rock Springs Capital Management reported no remaining ACELYRIN position as of Q4 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 141,876 ACELYRIN shares in Q4 2023, an estimated $1.44M.
  • Rock Springs Capital Management first reported a position in ACELYRIN in Q2 2023 and held it in 2 quarters.
  • Rock Springs Capital Management's ACELYRIN position peaked at $2.97M in Q2 2023.
  • 110 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.